000 | 01656nam a2200253Ia 4500 | ||
---|---|---|---|
001 | 36873 | ||
003 | IN-BdCUP | ||
005 | 20230421154919.0 | ||
008 | 230413s2023 000 0 eng | ||
020 | _a323509223 | ||
040 |
_beng _cIN-BdCUP |
||
041 | _aeng | ||
082 |
_a615.6 _bSHA |
||
245 | 0 |
_aDrug Delivery Nanosystems for Biomedical Applications / _cSharma, Chandra P. (Ed.) |
|
260 |
_aUnited states : _bElsevier, _c2018. |
||
300 |
_a451 p. ; _c24 cm. |
||
520 | _aDrug Delivery Nanosystems for Biomedical Application reviews some of the most challenging nanosystems with different routes of delivery that are useful for specific drugs, from both efficacy and bioavailability points-of-view. The chapters explore how this area is developing, the present state of the field, and future developments, in particular, inorganic, metallic, polymeric, composite and lipid nanosystems and their possible evolution to clinical applications. The book is a valuable research reference for both researchers and industrial partners who are not only interested in learning about this area, but also want to gain insights on how to move towards translational research. Focuses on applications, including tissue engineering and regenerative technologies, showing how nanosystems are used in practice Explores how nanosystems are used to deliver a variety of drugs, including peptides, hormone growth factors and genes Assesses the safety and nanotoxicity aspects of drug delivery nanosystems | ||
650 | _aMedical | ||
650 | _aDrug | ||
650 | _aNanosystems | ||
650 | _aBiomedical | ||
700 |
_aSharma, Chandra P. _eEditor |
||
942 |
_2ddc _cBK |
||
999 |
_c28537 _d28537 |